Role of interleukin 4 in Spanish multiple sclerosis patients

被引:20
|
作者
Urcelay, E
Santiago, JL
Mas, A
Martínez, A
de las Heras, V
Arroyo, R
de la Concha, EG
机构
[1] Hosp Univ San Carlos, Dept Immunol, Madrid 28040, Spain
[2] Hosp Univ San Carlos, Dept Neurol, Madrid, Spain
关键词
interleukin; 4; multiple sclerosis; susceptibility;
D O I
10.1016/j.jneuroim.2005.07.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 4 is a Th2 cytokine with potent anti-inflammatory properties. Protection from autoimmune encephalomyelitis and multiple sclerosis has been achieved with IL-4 therapy and IL-4 deficient mice developed a more severe form of clinical disease. Four polymorphisms within the IL-4 gene are in strong linkage disequilibrium, including one in the promoter at 590, which controls transcriptional activity. An MS protective role for the heterozygous genotype was confirmed in Spain (exon-1 + 33 C/T: p=0.003, OR [CI]=0.57 [0.38-0.84]), probably indicative of an MS protection haplotype at 5q31 locus, No difference among MS clinical forms or age at onset was detected. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 50 条
  • [31] Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
    Perriard, Guillaume
    Mathias, Amandine
    Enz, Lukas
    Canales, Mathieu
    Schluep, Myriam
    Gentner, Melanie
    Schaeren-Wiemers, Nicole
    Du Pasquier, Renaud A.
    JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [32] Impaired interleukin-12 production in multiple sclerosis patients.
    Robowsky-Kochan, C
    Molinaro, D
    Choudry, A
    Cook, SD
    FASEB JOURNAL, 1998, 12 (05): : A1102 - A1102
  • [33] Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
    Guillaume Perriard
    Amandine Mathias
    Lukas Enz
    Mathieu Canales
    Myriam Schluep
    Melanie Gentner
    Nicole Schaeren-Wiemers
    Renaud A. Du Pasquier
    Journal of Neuroinflammation, 12
  • [34] Interleukin 18 Polymorphisms and its serum level in Patients with Multiple Sclerosis
    Jahanbani-Ardakani, Hamidreza
    Alsahebfosoul, Fereshteh
    Etemadifar, Masoud
    Abtahi, Seyed-Hossein
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2019, 22 (04) : 474 - 476
  • [35] Serum level of interleukin-6 in Chinese patients with multiple sclerosis
    Chen, Ying-Chun
    Yang, Xin
    Miao, Ling
    Liu, Zhen-Guo
    Li, Wei
    Zhao, Zhong-Xin
    Sun, Xiao-Jiang
    Jiang, Guo-Xin
    Chen, Sheng-Di
    Cheng, Qi
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 249 (1-2) : 109 - 111
  • [36] Serum level of interleukin-6 in Chinese patients with multiple sclerosis
    Cheng, Q.
    Chen, Y. -C.
    Jiang, G. -X.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 674 - 675
  • [37] Interleukin 18 Receptor 1 expression distinguishes patients with multiple sclerosis
    Gillett, Alan
    Hedreul, Melanie Thessen
    Khademi, Mohsen
    Espinosa, Alexander
    Beyeen, Amennai D.
    Jagodic, Maja
    Kockum, Ingrid
    Harris, Robert A.
    Olsson, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (09) : 1056 - 1065
  • [38] Interleukin 2(-384) gene polymorphism in Greek patients with multiple sclerosis
    Aggelakis, K.
    Zacharaki, F.
    Kolia, P.
    Gkaraveli, M.
    Tsimourtou, V.
    Dardiotis, E.
    Dardioti, M.
    Xiromerisiou, G.
    Papadimitriou, A.
    Hadjigeorgiou, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 276 - 276
  • [39] Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis
    Jane E. Libbey
    Ikuo Tsunoda
    Robert S. Fujinami
    Journal of NeuroVirology, 2012, 18 : 471 - 478
  • [40] Anti-Interleukin-12 AntibodyPotential Role in Preventing Relapses of Multiple Sclerosis
    Robert J. Fox
    Abdolmohamad M. Rostami
    BioDrugs, 2000, 13 : 233 - 241